Our Newsletter / Blog
Health Outcomes Communicator
Welcome to the Health Outcomes Communicator blog! We are dedicated to helping our readers stay informed about the latest developments and best practices in health economics, outcomes research, and effective communication of healthcare information and data.
Sign-up and get the latest news straight to your inbox.
Presenteeism and the impact of appropriate pharmaceutical treatment on workplace costs
Exploring the role of pharmaceuticals in presenteeism
Bridging cultural gaps
An overview of cross-cultural communication, understanding oneself and others, and adapting communication styles for success
Drowning in email? Here are some life belts
Explore strategies to manage email overload and boost productivity by leveraging other communication tools.
ISPOR’s 12th annual international meeting
The International ISPOR meeting explores new tools and audiences in health outcomes research, discussing the media's role in conveying information about medical technologies, personalised medicine, and cost-effectiveness analysis
ASHE revisited
Explore the American Society of Health Economists (ASHE) one year after its first conference
WHC and ISMMP congresses
Summary of insights from the Fourth Annual World Health Care Congress and the International Society for Healthcare Publication Professionals annual meeting.
Health economists’ broader role in lifestyles, demographics, and risk management
The influence of economists in lifestyle and demographic issues
Making molehills out of mountains – of clinical data
Discover the process of summarising research results in a manuscript by focusing on the original research question and clear presentation
In praise of eloquence
Analyzing the reasons behind the decline of eloquence and proposing solutions to revive it
Risk/benefit decisions – who should be involved, and are there valid measurement methods?
An overview of approaches to include patient preferences in treatment decision-making processes
Industry commentary – Predictors of productivity
This article discusses the influence of new treatments on workplace productivity and the need to consider various social and economic factors in clinical trials
Industry commentary – Compulsory licences in Thailand override international patents
Merck cuts the price of Efavirenz in Thailand due to compulsory licences for generics, sparking a debate on the patent system and innovation
Subscribe to our newsletter
Get the latest news straight to your inbox.
Discover the Power of Communication with Rx
Embark on your medcomms journey with Rx today and experience the difference of working with a world-class medical communications agency.
